Urinary Alkalinizing Agents has 7 known drug interactions based on U.S. FDA drug labeling data. 1 are classified as major interactions requiring close medical supervision. Notable interactions include combinations with Lisdexamfetamine Dimesylate, Amphetamine, Benzphetamine Hydrochloride. Patients taking Urinary Alkalinizing Agents should inform their healthcare provider of all current medications — including over-the-counter drugs and supplements — to avoid potentially harmful combinations. Data sourced from OpenFDA and the NIH National Library of Medicine.
- Total
- 7
- Major
- 1
- Moderate
- 6
Major (1)
- Urinary Alkalinizing Agents + Lisdexamfetamine Dimesylate— Can increase blood levels and potentiate the action of amphetamine. Co-administration should be avoided.
Moderate (6)
- Urinary Alkalinizing Agents + Amphetamine— Increase blood levels and potentiate the action of amphetamine. Co-administration should be avoided.
- Urinary Alkalinizing Agents + Benzphetamine Hydrochloride— Urinary alkalinizing agents increase blood levels and decrease excretion of amphetamines.
- Urinary Alkalinizing Agents + Dextroamphetamine Saccharate, Amphetamine Aspartate Monohydrate, Dextroamphetamine Sulfate And Amphetamine Sulfate— Increase blood levels and potentiate the action of amphetamine.
- Urinary Alkalinizing Agents + Methenamine, Sodium Phosphate, Monobasic, Methylene Blue, And Hyoscyamine Sulfate— May cause urine to become alkaline, reducing effectiveness of methenamine by inhibiting its conversion to formaldehyde.
- Urinary Alkalinizing Agents + Methenamine, Sodium Phosphate, Monobasic, Monohydrate, Phenyl Salicylate, Methylene Blue, And Hyoscyamine Sulfate— May cause urine to become alkaline, reducing effectiveness of methenamine by inhibiting its conversion to formaldehyde.
- Urinary Alkalinizing Agents + Urinary Antiseptic Antispasmodic— May reduce effectiveness of methenamine by inhibiting its conversion to formaldehyde, causing urine to become alkaline.